Daniela Cigognini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniela Cigognini has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Gianmarco Corneo
2 shared publications- Pasquale Tripputi
Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Beldiletto 1, 20142 Milano, Italy
2 shared publications Alberto Zanella
1 shared publicationCaterina Pellegrini
1 shared publication- Elisa Fermo
SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122 Milan, Italy
1 shared publication - Monica Bignotto
Università degli Studi di Milano
1 shared publication
Latest Publications
- 1 April 2007
- Published by Elsevier in Leukemia Research
- Vol. 31 (4) , 477-482
HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms
- 1 April 2007
- Published by Elsevier in Leukemia Research
- Vol. 31 (4) , 477-482
HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms
- 9 November 2004
- Vol. 19 (3) , 171-4
Immunoglobulin gene rearrangements and in vitro growth of stromal cells are prognostic indexes in B-chronic lymphocytic leukemia.
B-chronic lymphocytic leukemia is a disease characterized by an accumulation of monoclonal B cells that are resistant to apoptosis. In chronic lymphocytic leukemia, the prognosis depends on the stage of the disease, according to the classifications of Rai and Binet. However, in recent years, the number of patients with very early disease (stage 0 of Rai) and without any clinical symptom, has considerably increased because of the extensive use of automatic apparatus for leukocyte counting and immunophenotypic analysis of lymphocytes. It has become, therefore, useful to find new prognostic criteria particularly for these patients. In the present study, 30 patients with B-chronic lymphocytic leukemia were investigated for stage of the disease, survival, immunoglobulin gene rearrangements, presence of nurse like cells in in vitro cultures and spontaneous clinical lymph node regression. We observed that all these criteria are useful prognostic indexes for the disease.
- 9 November 2004
- Vol. 19 (3) , 171-4
Immunoglobulin gene rearrangements and in vitro growth of stromal cells are prognostic indexes in B-chronic lymphocytic leukemia.
B-chronic lymphocytic leukemia is a disease characterized by an accumulation of monoclonal B cells that are resistant to apoptosis. In chronic lymphocytic leukemia, the prognosis depends on the stage of the disease, according to the classifications of Rai and Binet. However, in recent years, the number of patients with very early disease (stage 0 of Rai) and without any clinical symptom, has considerably increased because of the extensive use of automatic apparatus for leukocyte counting and immunophenotypic analysis of lymphocytes. It has become, therefore, useful to find new prognostic criteria particularly for these patients. In the present study, 30 patients with B-chronic lymphocytic leukemia were investigated for stage of the disease, survival, immunoglobulin gene rearrangements, presence of nurse like cells in in vitro cultures and spontaneous clinical lymph node regression. We observed that all these criteria are useful prognostic indexes for the disease.